Aqr Capital Management LLC / TMO
Aqr Capital Management LLC’s Thermo Fisher Scientific Inc Position
Does Aqr Capital Management LLC own Thermo Fisher Scientific Inc (TMO)? Yes — 125.7K shares worth $61M (+0.03% of its 13F portfolio) as of Q1 2026, down from 144.8K shares the prior filed quarter.
Position Value
$61M
Q1 2026
Shares
125.7K
% of Portfolio
+0.03%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 125.7K | $61M | +0.03% |
| Q4 2025 | 144.8K | $84M | +0.04% |
| Q3 2025 | 155.6K | $72M | +0.05% |
| Q2 2025 | 108.7K | $44M | +0.04% |
| Q1 2025 | 209.3K | $102M | +0.11% |
| Q4 2024 | 221.2K | $115M | +0.15% |
| Q3 2024 | 211.4K | $129M | +0.18% |
| Q2 2024 | 98.2K | $54M | +0.08% |
| Q1 2024 | 83.1K | $48M | +0.08% |
| Q4 2023 | 108.9K | $58M | +0.11% |
| Q3 2023 | 157.7K | $80M | +0.16% |
| Q2 2023 | 178.7K | $93M | +0.20% |
| Q1 2023 | 226.7K | $129M | +0.28% |
| Q4 2022 | 210.5K | $116M | +0.26% |
| Q3 2022 | 244.6K | $124M | +0.30% |
| Q2 2022 | 276.2K | $147M | +0.33% |
| Q1 2022 | 710.7K | $420M | +0.80% |
| Q4 2021 | 946.2K | $631M | +1.14% |
| Q3 2021 | 1.11M | $636M | +1.18% |
| Q2 2021 | 1.06M | $537M | +0.93% |
| Q1 2021 | 1.10M | $502M | +0.82% |
| Q4 2020 | 800.6K | $370M | +0.66% |
| Q3 2020 | 675.5K | $297M | +0.50% |
| Q2 2020 | 550.2K | $194M | +0.31% |
| Q1 2020 | 565.2K | $160M | +0.27% |
| Q4 2019 | 1.24M | $403M | +0.46% |
| Q3 2019 | 1.66M | $483M | +0.57% |
| Q2 2019 | 2.14M | $622M | +0.69% |
| Q1 2019 | 1.54M | $418M | +0.44% |
| Q4 2018 | 1.92M | $429M | +0.50% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aqr Capital Management LLC’s full portfolio or all institutional holders of TMO.